Schwab Yield Plus Class Action Settlement Reached

|

Charles Schwab Corp. has agreed to pay investors $200 million to settle a YieldPlus Fund class action lawsuit over losses their bond fund suffered as a result of the subprime mortgage market crash. 

The settlement was reached last week between the company and investors who claim that the company was deceptive about the nature of the YieldPlus funds. Investors say they lost $800 million when the bottom fell out of the fund in 2007, and Schwab still faces at least 194 individual stockbroker arbitration claims for up to $34 million. Those investors opted out of the class action lawsuit.

The Schwab YieldPlus funds are ultra-short bond funds that were heavily promoted as conservative investment alternatives to money market funds or cash. Despite being advertised to generate income with minimal changes in share price, the fund lost more than 30% of its value between June 2007 and June 2008 due to heavy investments in risky subprime mortgage securities, which some experts indicate violated the prospectus.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The funds lost much of their value when the sub-prime mortgage market crashed in late 2007, leaving investors with substantial losses. The investor claims allege that Schwab misled investors and failed to properly disclose the nature of the risks associated with certain securities held by the bond funds.

In October, Schwab announced that it had received a “Wells notice” from the U.S. Securities and Exchange Commission (SEC) indicating that they plan to recommend that the company be brought up on civil charges. No charges have yet been filed.

The company did not admit to any wrongdoing as part of the settlement, which reduced the company’s quarterly profits from $119 million to $14 million.


1 Comments


VEGA
I opted out…looking for a good attorney to win my case

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks.
A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case.